Fidelity Investments
AMBI

Fidelity Investments’s Ambit Biosciences Corp AMBI Stock Holding History

Fidelity Investments’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-398,679
Closed -$2.75M – 2881
2014
Q2 		$2.75M Sell
398,679
-520,005
-57% -$3.65M ﹤0.01% 2364
2014
Q1 		$8.38M Hold
918,684
– – ﹤0.01% 2074
2013
Q4 		$8.86M Buy
918,684
+116,434
+15% +$1.55M ﹤0.01% 2008
2013
Q3 		$12.4M Hold
802,250
– – ﹤0.01% 1882
2013
Q2 		$5.62M Buy
+802,250
New +$5.74M ﹤0.01% 2106

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Fidelity Investments's AMBI Position: Q3 2014 in Review

Fidelity Investments sold out of Ambit Biosciences Corp (AMBI) in Q3 2014, closing a stake of 398,679 shares — an estimated $2.75M sold.

Fidelity Investments first reported a position in AMBI in Q2 2013 and held it in 5 quarters. The position peaked at $12.4M in Q3 2013. 49 funds tracked by Wall St. Rank hold AMBI as of Q3 2014.

  • Fidelity Investments reported no remaining Ambit Biosciences Corp position as of Q3 2014 after selling out during the quarter.
  • Fidelity Investments sold 398,679 Ambit Biosciences Corp shares in Q3 2014, an estimated $2.75M.
  • Fidelity Investments first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 5 quarters.
  • Fidelity Investments's Ambit Biosciences Corp position peaked at $12.4M in Q3 2013.
  • 49 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q3 2014.

Based on Fidelity Investments's 13F filing for Q3 2014, filed 14 Nov 2014.